Kazuma Ogawa Selected Research

111indium-DTPA-Ac-TZ14011

5/2006

Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuma Ogawa Research Topics

Disease

31	Neoplasms (Cancer) 10/2022 - 05/2006
13	Neoplasm Metastasis (Metastasis) 01/2020 - 05/2006
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 06/2011
5	Myocardial Ischemia (Ischemic Heart Diseases) 10/2021 - 10/2008
5	Pain (Aches) 02/2009 - 07/2005
4	Carcinoma (Carcinomatosis) 03/2021 - 08/2008
3	Myocardial Infarction 02/2021 - 03/2013
3	Alzheimer Disease (Alzheimer's Disease) 11/2020 - 02/2016
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 11/2015
3	Ischemia 01/2015 - 07/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2018
2	Ventricular Remodeling 02/2021 - 01/2015
2	Infarction (Infarctions) 02/2021 - 10/2008
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Heart Diseases (Heart Disease) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Lung Neoplasms (Lung Cancer) 06/2020
1	Inflammation (Inflammations) 11/2019
1	Necrosis 05/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2019
1	Bone Resorption 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Osteoporosis 01/2019

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 01/2022 - 05/2006
8	RadiopharmaceuticalsIBA 01/2020 - 07/2005
7	LigandsIBA 01/2019 - 02/2009
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2011
5	PlatinumIBA 01/2022 - 01/2017
5	Radioisotopes (Radionuclides)IBA 01/2021 - 08/2008
5	sigma Receptors (sigma Receptor)IBA 01/2019 - 11/2009
5	Diphosphonates (Bisphosphonates)IBA 02/2009 - 07/2005
4	arginyl-glycyl-aspartic acidIBA 01/2022 - 08/2015
4	IntegrinsIBA 10/2021 - 08/2015
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 02/2009
4	Therapeutic UsesIBA 01/2020 - 01/2007
4	SolutionsIBA 11/2015 - 12/2009
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
3	Sigma-1 ReceptorIBA 10/2021 - 01/2018
3	Durapatite (Hydroxylapatite)IBA 04/2019 - 05/2006
3	GalliumIBA 04/2019 - 02/2009
3	hydroxide ionIBA 01/2018 - 09/2012
2	Tyrosine Kinase InhibitorsIBA 10/2022 - 03/2021
2	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 11/2020 - 01/2018
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2020 - 01/2017
2	Photosensitizing Agents (Photosensitizers)IBA 04/2020 - 01/2017
2	PorphyrinsIBA 04/2020 - 01/2017
2	Methionine (L-Methionine)FDA Link 11/2019 - 03/2013
2	Fluorouracil (Carac)FDA LinkGeneric 05/2019 - 01/2013
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2018 - 10/2017
2	Cholinergic Agents (Cholinergics)IBA 02/2016 - 02/2009
2	TenascinIBA 01/2015 - 07/2010
2	Phosphotransferases (Kinase)IBA 10/2011 - 01/2011
2	vesamicolIBA 11/2009 - 02/2009
2	perrhenate (rhenium oxide)IBA 01/2007 - 05/2006
1	osimertinibIBA 10/2022
1	Biological ProductsIBA 01/2022
1	ProdrugsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 01/2022
1	diamminedichlorodihydroxyplatinum IVIBA 01/2022
1	Prion ProteinsIBA 01/2022
1	cyclopentanolIBA 10/2021
1	Molecular Probes (Molecular Probe)IBA 03/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2021
1	Colchicine FDA LinkGeneric 02/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Vorinostat FDA Link 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 10/2020
1	rociletinibIBA 06/2020
1	GoldIBA 04/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020
1	Adenosine Triphosphate (ATP)IBA 04/2020
1	Radium-223IBA 01/2020
1	BombesinIBA 01/2020
1	Astatine-211IBA 01/2020
1	PhosphatidylserinesIBA 05/2019
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2019
1	Gallium-68IBA 04/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2019
1	Large Neutral Amino Acid-Transporter 1IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	IonsIBA 01/2019
1	PolyaminesIBA 01/2019
1	quinolineIBA 01/2019
1	Citric Acid (Citrate)FDA LinkGeneric 01/2019
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019
1	Lanthanoid Series Elements (Lanthanides)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 10/2018

Therapy/Procedure

10	Therapeutics 01/2022 - 08/2008
3	Intravenous Administration 05/2013 - 12/2009
2	Photochemotherapy (Photodynamic Therapy) 04/2020 - 01/2017
2	Intravenous Injections 09/2012 - 11/2009
1	Precision Medicine 01/2022
1	Castration 01/2020
1	Aftercare (After-Treatment) 05/2019
1	Ovariectomy (Oophorectomy) 01/2019